The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Am I >> I think that there were some I think that Dudley Lamming sent the um and Dudley's a great scientist and a good friend who studies protein mainly in mice and other things uh but also a little bit humans. Um, I think he cited a couple of references and I think they were from Luigi Fontana if I recall correctly and there was some short-term trials in patients with cancer and I don't remember all the details but I I really see those as you know.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.